Raffel L J, Vadheim C M, Roth M P, Klein R, Moss S E, Rotter J I
Department of Pediatrics, University of Maryland School of Medicine, Baltimore.
Diabetologia. 1991 Sep;34(9):680-3. doi: 10.1007/BF00400999.
Recent data suggest genetic contributions to the microvascular complications of Type 1 (insulin-dependent) diabetes mellitus. Most research has focused on the HLA region, and the potential role of other genetic loci has not been adequately explored. We examined the possible relationship between DNA polymorphisms in the region 5' to the insulin gene on chromosome 11 and diabetic nephropathy. This was done by comparison of those diabetic patients homozygous for class 1 alleles at the 5' insulin gene polymorphism locus to 1/3 heterozygotes in a well-characterized series of 324 insulin-requiring diabetic patients from the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Proteinuria (defined as greater than or equal to 0.3 g protein/l urine), was used as suggestive evidence for diabetic nephropathy. Hypertension, a frequent associated finding in diabetic patients with nephropathy, was defined as a blood pressure greater than 140/90 or a history of previous treatment of hypertension. The two genotypically defined groups did not differ from each other in regard to sex ratio, age at diagnosis, age at examination, duration of diabetes, body mass, HbAlc or C-peptide. The 1+1 group had a higher prevalence of proteinuria, 29% as compared to 16.2% in other genotypes (p less than 0.05). There was no significant difference in the frequency of hypertension between the two genotypic groups. This finding suggests that the 5' insulin gene polymorphism may be associated with risk for nephropathy, but the pathophysiologic mechanism remains unclear.
近期数据表明,基因因素在1型(胰岛素依赖型)糖尿病微血管并发症中发挥作用。多数研究聚焦于HLA区域,而其他基因位点的潜在作用尚未得到充分探究。我们研究了11号染色体上胰岛素基因5'端区域的DNA多态性与糖尿病肾病之间的可能关系。通过比较威斯康星糖尿病视网膜病变流行病学研究中324例需要胰岛素治疗的糖尿病患者中,胰岛素基因5'多态性位点1类等位基因纯合子糖尿病患者与1/3杂合子患者来进行此项研究。蛋白尿(定义为尿蛋白≥0.3g/L)被用作糖尿病肾病的提示性证据。高血压是糖尿病肾病患者常见的伴随症状,定义为血压大于140/90或有高血压既往治疗史。这两组基因分型定义的患者在性别比例、诊断年龄、检查年龄、糖尿病病程、体重、糖化血红蛋白或C肽方面并无差异。1+1组蛋白尿患病率更高,为29%,而其他基因型组为16.2%(p<0.05)。两组基因分型组之间高血压发生率无显著差异。这一发现表明,胰岛素基因5'多态性可能与肾病风险相关,但病理生理机制仍不清楚。